TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9279213

Group type: EXPERIMENTAL
Intervention: Inhaled ET-1 (doubling dose range, 0.96 to 15.36 nmol)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Methacholine (doubling dose range, 0.33 to 21.0 mumol)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 13

Group type: COMPARATOR
Intervention: ET-1 (in healthy volunteers)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Noninvasive blood pressure measurements
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Plasma ET-1 measurements
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oxygen saturation monitoring
Number of subjects: 13
Study: 8345072

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotrophin (HCG) (9000 IU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gonadotrophin-releasing hormone agonist (GnRHa)
Number of subjects: 16
Study: 3729714

Group type: EXPERIMENTAL
Intervention: Low-dose subcutaneous heparin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29024310

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (SBP target <120 mm Hg)
Number of subjects: 9097

Group type: COMPARATOR
Intervention: Standard blood pressure control (SBP target <140 mm Hg)
Number of subjects: 9097
Study: 30193440

Group type: EXPERIMENTAL
Intervention: Emotionally loaded stimulus - subject’s second name
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotionally loaded stimulus - random shuffled letters of second name
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotionally loaded stimulus - graphic representation of simple arithmetic expression with correct answer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotionally loaded stimulus - graphic representation of simple arithmetic expression with incorrect answer
Number of subjects: 0
Study: 25274610

Group type: COMPARATOR
Intervention: Dasatinib (100 mg) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg) with 1500 mg BHCl after rabeprazole pretreatment
Number of subjects: 0
Study: 22462626

Group type: EXPERIMENTAL
Intervention: Vardenafil 5 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no PDE5 inhibitors)
Number of subjects: 36
Study: 20543734

Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Dynamic weight training (DWT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 35
Study: 18329596

Group type: EXPERIMENTAL
Intervention: Normal weight and overweight women
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Obese women
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Women with high depression scores
Number of subjects: 349
Study: 15919441

Group type: EXPERIMENTAL
Intervention: Tacrolimus (n = 50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cyclosporine microemulsion (n = 51)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Tacrolimus and Cyclosporine microemulsion
Number of subjects: 101
Study: 12050248

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) at a dose of 12.5 microg/kg per day for 12 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lean body mass
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DHEAS
Number of subjects: 16
Study: 10332946

Group type: EXPERIMENTAL
Intervention: Naps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modafinil (MODIODAL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of naps and modafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 9199744

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.01% with acyclovir 3%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 0.03% with acyclovir 3%
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo with acyclovir 3%
Number of subjects: 45
Study: 1712266

Group type: EXPERIMENTAL
Intervention: Cilazapril 30mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilazapril 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enalapril 10mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilazapril (1.25, 3.75, 10 and 30mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilazapril and Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilazapril and Propranolol combination
Number of subjects: 0
Study: 6857385

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 280

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 280
Study: 31802111

Group type: EXPERIMENTAL
Intervention: Accelerometer-measured physical activity
Number of subjects: 79448

Group type: EXPERIMENTAL
Intervention: Serum iron
Number of subjects: 79448

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 79448

Group type: EXPERIMENTAL
Intervention: Monounsaturated fat
Number of subjects: 79448

Group type: EXPERIMENTAL
Intervention: Height
Number of subjects: 79448
Study: 29482936

Group type: EXPERIMENTAL
Intervention: Sacral Neuromodulation (SNM)
Number of subjects: 386

Group type: COMPARATOR
Intervention: OnabotulinumtoxinA (BTX)
Number of subjects: 386
Study: 27579803

Group type: EXPERIMENTAL
Intervention: MTPT and medicine ball exercises
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MTPT and stretching
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 100
Study: 25799801

Group type: EXPERIMENTAL
Intervention: Fentanyl 20 microgram (0.4 ml) added to 0.5% bupivacaine heavy 2 ml (Group B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.5% bupivacaine heavy 2.4 ml (Group A)
Number of subjects: 70
Study: 21848849

Group type: EXPERIMENTAL
Intervention: 400 ppm LA supplementation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 600 ppm LA supplementation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 800 ppm LA supplementation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid supplementation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Weight gains of piglets from sows fed 800 ppm LA diets
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: LA-supplemented diets
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 160
Study: 19268165

Group type: EXPERIMENTAL
Intervention: Program of Reinforcing Autonomy and Social Capacities (PRACS)
Number of subjects: 0
Study: 17200838

Group type: EXPERIMENTAL
Intervention: MK-0524 25 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MK-0524 100 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15198882

Group type: EXPERIMENTAL
Intervention: Immune enhancing enteral diet
Number of subjects: 124

Group type: COMPARATOR
Intervention: Isocaloric and isonitrogenous control enteral diet
Number of subjects: 124
Study: 12365909

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy
Number of subjects: 402

Group type: COMPARATOR
Intervention: Placebo (original assignment)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Verteporfin therapy (original assignment)
Number of subjects: 402
Study: 16495883

Group type: EXPERIMENTAL
Intervention: Biological supplement (FloRelax®, Sanofi Winthrop) for 6 weeks
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control group (only diet)
Number of subjects: 380
Study: 8087928

Group type: EXPERIMENTAL
Intervention: Chelation therapy (EDTA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Chelation therapy
Number of subjects: 32
Study: 2571759

Group type: EXPERIMENTAL
Intervention: Pyrimethamine (25 mg weekly for suppressive prophylaxis)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pyrimethamine (25 mg weekly after chloroquine 25 mg/kg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (no prophylaxis after chloroquine 25 mg/kg)
Number of subjects: 88
Study: 4835462

Group type: EXPERIMENTAL
Intervention: Early mobilization (mobilized immediately and discharged after 9 days)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Late mobilization (mobilized on the 9th day and discharged after 16 days)
Number of subjects: 189
Study: 30894038

Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 366

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 366
Study: 30115183

Group type: EXPERIMENTAL
Intervention: Smartphone application
Number of subjects: 42

Group type: COMPARATOR
Intervention: Booklet (paper form)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both interventions (smartphone application and booklet)
Number of subjects: 42
Study: 25194436

Group type: EXPERIMENTAL
Intervention: Adenosine stress
Number of subjects: 200

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rest and stress
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Stress
Number of subjects: 200
Study: 22847995

Group type: EXPERIMENTAL
Intervention: Resistance exercise (using resistance bands)
Number of subjects: 15
Study: 21951630

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 848

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 848

Group type: EXPERIMENTAL
Intervention: SYNTAX score
Number of subjects: 848

Group type: EXPERIMENTAL
Intervention: Clinical SYNTAX score (CSS)
Number of subjects: 848
Study: 18489935

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 16223747

Group type: EXPERIMENTAL
Intervention: hGH treatment (4 IU/m2/day for two years)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: hGH treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 12931293

Group type: EXPERIMENTAL
Intervention: Stretta procedure using radiofrequency (RF) energy delivered to the distal lower esophageal sphincter (LES) and gastric cardia.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control (not explicitly detailed in the abstract).
Number of subjects: 0
Study: 11054340

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (0.1%) administered four times daily
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (0.1%) administered twice daily
Number of subjects: 31
Study: 8776496

Group type: EXPERIMENTAL
Intervention: 100-dot patterns with no constraints
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 100-dot patterns with constraints (no dot within fixed distance, uniform dot distribution)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Increasing number of dots from 10 to 80
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Number of dots per se
Number of subjects: 100
Study: 1607030

Group type: EXPERIMENTAL
Intervention: Preservation of the minor pectoralis muscle
Number of subjects: 100

Group type: COMPARATOR
Intervention: Removal of the minor pectoralis muscle
Number of subjects: 100
Study: 7058425

Group type: EXPERIMENTAL
Intervention: Accurette
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vabra aspirator
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dilation and curettage (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Accurette and Vabra aspirator
Number of subjects: 40
Study: 31942669

Group type: EXPERIMENTAL
Intervention: High Intensity Training (HIT) - 4 × 30 s cycle sprints (2 min recovery) at 150% of maximum wattage achieved during assessment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 12
Study: 30343411

Group type: EXPERIMENTAL
Intervention: CDT plus Linfadren® (study group, n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CDT (control group, n=25)
Number of subjects: 50
Study: 28063976

Group type: EXPERIMENTAL
Intervention: Jaw-opening exercise (JE), n=13
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo exercise (PE), n=12
Number of subjects: 25
Study: 26397721

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 89
Study: 23808594

Group type: EXPERIMENTAL
Intervention: Nimodipine AP (Tropocer®) 90 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nimodipine (Nimotop®) 30 mg three times daily
Number of subjects: 0
Study: 20801601

Group type: EXPERIMENTAL
Intervention: Patient-centered care by family physicians
Number of subjects: 509

Group type: COMPARATOR
Intervention: Patient-centered care by general internists
Number of subjects: 509
Study: 18272244

Group type: EXPERIMENTAL
Intervention: Androgenic anabolic steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-free bodybuilders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary counterparts
Number of subjects: 0
Study: 17476865

Group type: EXPERIMENTAL
Intervention: Group 1 liver biopsies (specimens at least 15 mm in length with >= 4 portal tracts)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Group 2 liver biopsies (specimens at least 10 mm in length with >= 4 portal tracts)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sampling discordance for portal fibrosis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sampling discordance for zone 3 fibrosis
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sampling discordance for ballooning degeneration
Number of subjects: 31
Study: 15090482

Group type: EXPERIMENTAL
Intervention: Appendicular lean soft tissue (ALST) estimates by dual‐energy X‐ray absorptiometry (DXA)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: ALST estimates with age included in the model
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: ALST estimates with age, sex, and race included in the model
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Model 1 applied to AN patients with BMI >16 kg/m(2)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: DXA-based models
Number of subjects: 270
Study: 12185401

Group type: EXPERIMENTAL
Intervention: Levodopa (200 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9501711

Group type: EXPERIMENTAL
Intervention: Protein:creatinine ratio in spot morning urine samples
Number of subjects: 177
Study: 7715221

Group type: COMPARATOR
Intervention: Standard transplantation (group I)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Anatomic transplantation (group II)
Number of subjects: 78
Study: 2565098

Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: astemizole
Number of subjects: 40
Study: 14057

Group type: EXPERIMENTAL
Intervention: Sulphasalazine for one year
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 31264119

Group type: EXPERIMENTAL
Intervention: Unilateral lobectomy (Group I, n=127)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Total thyroidectomy (Group II, n=128)
Number of subjects: 255
Study: 28483498

Group type: COMPARATOR
Intervention: 100% RDA (0.8g·kg‐1·d‐1) plus placebo injections
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 100% RDA (0.8g·kg‐1·d‐1) plus 100mg testosterone enanthate injections
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 163% RDA (1.3g·kg‐1·d‐1) plus placebo injections
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 163% RDA (1.3g·kg‐1·d‐1) plus testosterone injections
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 92
Study: 26362001

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy
Number of subjects: 375

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 375
Study: 23904400

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus leuprolide acetate
Number of subjects: 220

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 220
Study: 21707189

Group type: EXPERIMENTAL
Intervention: Prize contingency management (CM) treatment
Number of subjects: 78
Study: 19092784

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17156398

Group type: EXPERIMENTAL
Intervention: Thalidomide (THAL)
Number of subjects: 668

Group type: COMPARATOR
Intervention: No Thalidomide (Control)
Number of subjects: 668
Study: 14704844

Group type: EXPERIMENTAL
Intervention: BCS-RT (breast-conserving surgery followed by adjuvant radiotherapy)
Number of subjects: 290

Group type: COMPARATOR
Intervention: MRM (modified radical mastectomy)
Number of subjects: 290
Study: 12096159

Group type: EXPERIMENTAL
Intervention: El Tren (The Train) board game intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional social skills training
Number of subjects: 0
Study: 10186932

Group type: EXPERIMENTAL
Intervention: Management training seminar held at a college for 1 year directed primarily at human resource managers.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison group (not explicitly defined in the abstract).
Number of subjects: 20
Study: 8617412

Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2568639

Group type: EXPERIMENTAL
Intervention: 4 mg zuclopenthixol daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: 1 mg haloperidol in the morning and 5 mg levomepromazine in the evening
Number of subjects: 48
Study: 893737

Group type: EXPERIMENTAL
Intervention: Intravenous hydralazine, 0.15 mg/kg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intravenous propranolol, 0.1 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intravenous hydralazine, 0.15 mg/kg after phentolamine infusion (0.01 or 0.02 mg/kg per minute)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intravenous hydralazine, 0.30 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intravenous hydralazine, 0.60 mg/kg
Number of subjects: 11
Study: 30820661

Group type: EXPERIMENTAL
Intervention: Severe hypoxia (FIO2 0.114)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate hypoxia (FIO2 0.152)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normoxia (FIO2 0.202)
Number of subjects: 8
Study: 29197067

Group type: EXPERIMENTAL
Intervention: Community health campaigns (CHCs)
Number of subjects: 4944

Group type: COMPARATOR
Intervention: Health facilities
Number of subjects: 4944
Study: 26672890

Group type: EXPERIMENTAL
Intervention: Post-dilution online haemodiafiltration (OL-HDF)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Haemodialysis
Number of subjects: 355
Study: 25311446

Group type: EXPERIMENTAL
Intervention: STEPS‐UP collaborative care
Number of subjects: 666

Group type: COMPARATOR
Intervention: Usual collaborative primary care
Number of subjects: 666
Study: 22313276

Group type: EXPERIMENTAL
Intervention: Opti‐Bond FL
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Scotchbond 1 XT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PQ1
Number of subjects: 50
Study: 20101007

Group type: EXPERIMENTAL
Intervention: DASH diet plus weight management
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: DASH diet alone
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual diet controls
Number of subjects: 144
Study: 17729060

Group type: EXPERIMENTAL
Intervention: Salmeterol (a long-acting β2-agonist) in combination with fluticasone propionate (an inhaled corticosteroid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium bromide (an anticholinergic bronchodilator)
Number of subjects: 0
Study: 15841623

Group type: EXPERIMENTAL
Intervention: 18 U of BTX‐A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12 U of BTX‐A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6 U of BTX‐A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 U of BTX‐A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11818765

Group type: COMPARATOR
Intervention: loratadine (20 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: ranitidine (300 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 9923421

Group type: EXPERIMENTAL
Intervention: 25% maximum isometric contraction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 75% maximum isometric contraction
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 12
Study: 8678246

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (40 mg.kg‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 2127959

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 605761

Group type: EXPERIMENTAL
Intervention: 10 microgram/kg of naloxone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 15 microgram/kg of naloxone
Number of subjects: 55

Group type: COMPARATOR
Intervention: naloxone-treated patients
Number of subjects: 55

Group type: COMPARATOR
Intervention: naloxone
Number of subjects: 55
Study: 31020900

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 30621

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 30621

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30621

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg vs Atorvastatin 80 mg
Number of subjects: 30621

Group type: EXPERIMENTAL
Intervention: Kidney function as a predictor of cardiovascular outcomes
Number of subjects: 30621
Study: 28755550

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (placebo)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACE)
Number of subjects: 40
Study: 25775661

Group type: EXPERIMENTAL
Intervention: Intralesional meglumine antimoniate (MA) once a week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical application of trichloroacetic acid (TCA) 50% solution once weekly
Number of subjects: 60
Study: 23153673

Group type: EXPERIMENTAL
Intervention: Intensive treatment (INT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment (CONV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSPNE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSPNE adjusted for mean A1c
Number of subjects: 0